IMAGE IN CARDIOLOGY

DOI: 10.4244/EIJV10I8A170

Self-expandable valve implantation within a failed balloon-expandable valve

Ran Kornowski*, MD, FESC, FACC; Pablo Codner, MD; Hana Vaknin-Assa, MD; Abid Assali, MD

Percutaneous implantation of an aortic valve is an alternative for the treatment of bioprosthetic surgical valve deterioration. Less is known about the treatment options for failed catheter implanted valves. We report herein a case of an early degeneration of the Edwards SAPIEN XT balloon-expandable valve (Edwards Lifesciences, Irvine, CA, USA) which we treated using the successful implantation of a self-expandable CoreValve® (Medtronic, Minneapolis, MN, USA) in a patient sustaining haemodialysis. The patient was referred to our service due to signs and symptoms of severe aortic stenosis 20 months after transcatheter aortic valve implantation (TAVI) using the balloon-expandable Edwards SAPIEN XT 23 mm device. Echo findings showed thickened and poorly mobile aortic valve leaflets, and pressure gradients were 90/60 mmHg. Following consideration of the treatment options, we performed a second valve-in-valve TAVI procedure using a self-expandable CoreValve Evolut 23 mm device (Medtronic). The procedure was carried out smoothly and without complications (Figure 1, Online Figure 1, Moving image 1-Moving image 6). The valve residual gradient was 28/18 mmHg and without residual paravalvular leak. This case indicates a possible relationship between the earlier catheter-based valve degeneration and the renal insufficiency/dialysis treatment characterising our patient. Importantly, it may also point towards an expansion of the future treatment options following late failure of catheter-based valve devices.

Figure 1. CoreValve Evolut 23 mm within Edwards SAPIEN XT 23 mm. A) A stiff guidewire has been crossed to the left ventricle through the Edwards SAPIEN XT valve. B) The self-expandable CoreValve within the Edwards SAPIEN XT in the pre-deployment phase. C) Final position of the self-expandable device within the balloon-expandable valve.

Conflict of interest statement

The authors have no conflicts of interest to declare.

Online data supplement

Moving image 1. Pre valve-in-valve echo.

Moving image 2. Pre valve-in-valve angio 1.

Moving image 3. Pre valve-in-valve angio 2.

Moving image 4. Deployment landing angio.

Moving image 5. Deployment completion angio.

Moving image 6. Post valve-in-valve angio.

Online Figure 1. Haemodynamic tracing pre- and post-deployment.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Pre valve-in-valve echo.

Moving image 2. Pre valve-in-valve angio 1.

Moving image 3. Pre valve-in-valve angio 2.

Moving image 4. Deployment landing angio.

Moving image 5. Deployment completion angio.

Moving image 6. Post valve-in-valve angio.

Volume 10 Number 8
Dec 22, 2014
Volume 10 Number 8
View full issue


Key metrics

Suggested by Cory

INTERVENTIONAL FLASHLIGHT

10.4244/EIJ-D-17-00578 Mar 20, 2018
Valve-in-valve transcatheter aortic valve implantation into a novel, sutureless bioprosthesis: technical considerations
Andreas M et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJV11I11A255 Feb 12, 2016
Edwards SAPIEN 3 implanted in a failing aortic bioprosthesis: first report
Molina-Martin de Nicolas J et al
free

IMAGE IN CARDIOLOGY

10.4244/EIJY15M02_06 Jul 20, 2015
Transcatheter Lotus valve implantation in a regurgitant SAPIEN 3 valve
Van Mieghem NM et al
free

10.4244/EIJV14I4A67 Jul 20, 2018
TAVI durability beyond five years: no alarms, but stay alert
Eltchaninoff H et al
free
Trending articles
310.18

State-of-the-Art Review

10.4244/EIJ-D-21-00695 Nov 19, 2021
Transcatheter treatment for tricuspid valve disease
Praz F et al
free
166.7

Expert review

10.4244/EIJ-D-21-00690 May 15, 2022
Crush techniques for percutaneous coronary intervention of bifurcation lesions
Moroni F et al
free
92.2

State-of-the-Art Review

10.4244/EIJ-D-20-01296 Aug 27, 2021
Management of cardiogenic shock
Thiele H et al
free
76

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
72.85

State-of-the-Art

10.4244/EIJ-D-24-00386 Feb 3, 2025
Mechanical circulatory support for complex, high-risk percutaneous coronary intervention
Ferro E et al
free
58.3

Clinical research

10.4244/EIJ-D-23-00344 Sep 18, 2023
Clinical outcomes of TAVI with the Myval balloon-expandable valve for non-calcified aortic regurgitation
Sanchez-Luna JP et al
free
56.65

Clinical research

10.4244/EIJ-D-20-01155 Oct 20, 2021
A deep learning algorithm for detecting acute myocardial infarction
Liu W et al
free
33.9

CLINICAL RESEARCH

10.4244/EIJ-D-17-00381 Oct 11, 2017
Stent malapposition and the risk of stent thrombosis: mechanistic insights from an in vitro model
Foin N et al
free
33.65

State-of-the-Art

10.4244/EIJ-D-23-00606 Jan 1, 2024
Targeting inflammation in atherosclerosis: overview, strategy and directions
Waksman R et al
free
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 7.6
2023 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2024)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved